CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Indegodevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02202538
NCT02202538N/ACompleted
CompareCT.gov

Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).

Parker Hannifin Corporation·interventional·Posted Jul 29, 2014·Updated Jul 25, 2017

In Brief

A clinical study evaluating Indego for Spinal Cord Injury. Completed, enrolled 53 participants across 5 sites.

Detailed Summary

This study will evaluate the Indego® device for safety and effectiveness at allowing persons with SCI who are non-ambulatory or poorly ambulatory to stand up and walk under a variety of conditions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injury
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 29, 2014
Enrollment StartAug 1, 2014
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.9 years ago

Interventions

Indegodevice

Indego